Best medical care

PreclinicalSmall molecule

Best medical care is one of 5 small molecule programs targeting Intracranial Hypertension. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Intracranial HypertensionActive, not recruiting

Intracranial HypertensionPreclinical

Active, not recruiting

Competition

Competitive Landscape

4 competitors in Intracranial Hypertension

#DrugCompanyPhaseTrials

Ozempic

Novo Nordisk

Approved

2 2

Mounjaro

Eli Lilly

Approved

1 3

Osmitrol

BB. Braun Medical Inc.

Approved

2 4

Nacl

Bayer

Preclinical

1 5

Best medical care

UUniversity Hospital, Grenoble

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2029

N/ARecruiting

Intracranial Hypertension

NCT06919744

Clinical

Trials by Indication[1]

Intracranial Hypertension1 trial

Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase

Recruiting·UUniversity Hospital, Montpellier·N/A·NCT06919744·114 enrolled

Type 1 Diabetes1 trial

Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes

Unknown status·UUniversity Hospital, Grenoble·Phase 3·NCT02854696·42 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Best medical care. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Best medical care compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Best medical care. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Grenoble company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospital, Grenoble

Best medical care

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2029

Trials by Indication[1]

Intracranial Hypertension1 trial

Type 1 Diabetes1 trial

References

Drug Info

Quick Facts

Related News